Nab-Paclitaxel Based Chemotherapy in the Treatment of Advanced Epithelioid Hemangioendothelioma: A Single-Institution Experience
Nab-paclitaxel based chemotherapy may offer an effective treatment option for patients with advanced EHE exhibiting adverse prognostic factors. However, further clinical trials are required to confirm its efficacy.
Authors
- Ruiquan Zhou
- Tiantong Liu (ORCID: https://orcid.org/0000-0002-3780-9431)
- Peijun Yang (ORCID: https://orcid.org/0000-0001-5138-3003)
- Shuang Si
- Xiaolei Liu (ORCID: https://orcid.org/0000-0003-4337-0899)
- Haidong Tan (ORCID: https://orcid.org/0000-0002-8675-0990)
- Liguo Liu (ORCID: https://orcid.org/0000-0003-2674-9928)
Institutions
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- Cancer Management and Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/cmar.s508673
- Primary Topic
- Vascular Tumors and Angiosarcomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China-Japan Friendship Hospital